Plant metabolite diosmin as the therapeutic agent in human diseases

Q2 Agricultural and Biological Sciences Current Research in Pharmacology and Drug Discovery Pub Date : 2022-01-01 DOI:10.1016/j.crphar.2022.100122
Saad Mustafa , Mahmood Akbar , Mohammad Aasif Khan , Kumari Sunita , Shabana Parveen , Jogendra Singh Pawar , Sheersh Massey , Nupur Rani Agarwal , Syed Akhtar Husain
{"title":"Plant metabolite diosmin as the therapeutic agent in human diseases","authors":"Saad Mustafa ,&nbsp;Mahmood Akbar ,&nbsp;Mohammad Aasif Khan ,&nbsp;Kumari Sunita ,&nbsp;Shabana Parveen ,&nbsp;Jogendra Singh Pawar ,&nbsp;Sheersh Massey ,&nbsp;Nupur Rani Agarwal ,&nbsp;Syed Akhtar Husain","doi":"10.1016/j.crphar.2022.100122","DOIUrl":null,"url":null,"abstract":"<div><p>Plant-derived flavonoids have been the focus of research for many years mainly in the last decade owing to their therapeutic properties. So far, about 4000 flavonoids have been identified from plants and diosmin (a flavone glycoside) is one of them. Online databases, previous studies, and reviews have been used to gather information on anti-oxidant, immunomodulatory, anti-cancer, anti-parasitic, and anti-microbialproperties of diosmin. Effects of diosmin in combination with other flavonoids have been reviewed thoroughly and its administrative routes are also summarized. Additionally, we studied the effect of diosmin on critical protein networks. It exhibits therapeutic effects in diabetes and its associated complications such as neuropathy and dyslipidemia. Combination of diosmin with hesperidin is found to be very effective in the treatment of chronic venous insufficiency and haemorrhoids. Diosmin is an exquisite therapeutic agent alone as well as in combination with other flavonoids.</p></div>","PeriodicalId":10877,"journal":{"name":"Current Research in Pharmacology and Drug Discovery","volume":"3 ","pages":"Article 100122"},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/81/5d/main.PMC9780066.pdf","citationCount":"10","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Research in Pharmacology and Drug Discovery","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590257122000426","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Agricultural and Biological Sciences","Score":null,"Total":0}
引用次数: 10

Abstract

Plant-derived flavonoids have been the focus of research for many years mainly in the last decade owing to their therapeutic properties. So far, about 4000 flavonoids have been identified from plants and diosmin (a flavone glycoside) is one of them. Online databases, previous studies, and reviews have been used to gather information on anti-oxidant, immunomodulatory, anti-cancer, anti-parasitic, and anti-microbialproperties of diosmin. Effects of diosmin in combination with other flavonoids have been reviewed thoroughly and its administrative routes are also summarized. Additionally, we studied the effect of diosmin on critical protein networks. It exhibits therapeutic effects in diabetes and its associated complications such as neuropathy and dyslipidemia. Combination of diosmin with hesperidin is found to be very effective in the treatment of chronic venous insufficiency and haemorrhoids. Diosmin is an exquisite therapeutic agent alone as well as in combination with other flavonoids.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
植物代谢物薯蓣皂苷作为人类疾病的治疗剂
植物源性黄酮类化合物近年来一直是研究的热点,主要是近十年来由于其治疗特性。迄今为止,已从植物中鉴定出约4000种黄酮类化合物,薯蓣皂苷(一种黄酮类苷)就是其中之一。在线数据库、先前的研究和综述已被用于收集薯蓣皂苷的抗氧化、免疫调节、抗癌、抗寄生虫和抗微生物特性的信息。综述了薯蓣皂苷与其他类黄酮的联用作用,并对其给药途径进行了综述。此外,我们还研究了薯蓣皂苷对关键蛋白质网络的影响。它对糖尿病及其相关并发症如神经病变和血脂异常有治疗作用。地奥司明与橙皮苷联合治疗慢性静脉功能不全和痔疮是非常有效的。薯蓣皂苷是一种精美的治疗剂单独以及与其他类黄酮的组合。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Current Research in Pharmacology and Drug Discovery
Current Research in Pharmacology and Drug Discovery Agricultural and Biological Sciences-Animal Science and Zoology
CiteScore
6.40
自引率
0.00%
发文量
65
审稿时长
40 days
期刊最新文献
Editorial Board Table of Contents Development of Recombinant Antibody by Yeast Surface Display Technology Papaverine attenuates the progression of alpha naphthylisothiocyanate induce cholestasis in rats Long-term effects of neonatal pain and sucrose treatment
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1